![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yuan Liangping Santi Mariarita Rushing Elisabeth Cornelison Robert MacDonald Tobey
Publisher: Springer Publishing Company
ISSN: 0262-0898
Source: Clinical and Experimental Metastasis, Vol.27, Iss.7, 2010-10, pp. : 481-491
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma
By Ong Christy C. Jubb Adrian M. Jakubiak Diana Zhou Wei Rudolph Joachim Haverty Peter M. Kowanetz Marcin Yan Yibing Tremayne Jarrod Lisle Richard Harris Adrian L. Friedman Lori S. Belvin Marcia Middleton Mark R. Blackwood Elizabeth M. Koeppen Hartmut Hoeflich Klaus P.
Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Overexpression of p21-activated kinase 1 promotes endometrial cancer progression
Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wang Lin Chen Chen Feng Shuzhi Lei Ping Tian Jianli
Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. :